CROSS-GENERATIONAL IMPACT OF DORMANT GENES: LEGAL, ETHICAL AND REGULATORY FRAMEWORK

1. INTRODUCTION

The cross-generational impact of dormant genes concerns the possibility that genetic variations or previously inactive genetic sequences may influence biological characteristics, disease susceptibility and health outcomes across successive generations. Dormant genes are generally understood as genes that are not actively expressed under particular biological conditions. Their expression may change through developmental processes, environmental influences, regulatory mechanisms and epigenetic modifications.

The transmission of genetic information from parents to offspring raises important legal questions concerning reproductive autonomy, genetic privacy, informed consent, discrimination, medical negligence, biotechnology research and intergenerational responsibility. Although genetic inheritance is scientifically established, the reactivation of a particular dormant gene does not necessarily occur in every generation.

2. SCIENTIFIC AND BIOLOGICAL BASIS

A. GENETIC INHERITANCE

Genes are transmitted through reproductive cells. Certain inherited genetic variations may remain clinically unexpressed in one generation but become relevant in another generation because of inheritance patterns or interactions with other genetic factors.

B. EPIGENETIC INHERITANCE

Epigenetic mechanisms influence gene expression without changing the underlying DNA sequence. DNA methylation, histone modifications and regulatory RNA mechanisms are important examples.

Some epigenetic effects may persist across generations, although the extent and mechanisms of stable inheritance in humans remain subjects of scientific investigation.

C. DORMANT GENES AND DISEASE SUSCEPTIBILITY

Previously unexpressed genetic variations may become clinically relevant because of environmental exposure, ageing, hormonal changes or interactions with other genes. This creates challenges for genetic counselling and predictive medicine.

3. INTERNATIONAL LEGAL FRAMEWORK

A. UNIVERSAL DECLARATION ON THE HUMAN GENOME AND HUMAN RIGHTS, 1997

UNESCO's Declaration recognizes the human genome as part of the fundamental unity of humanity. It establishes principles concerning human dignity, genetic research, informed consent and protection against genetic discrimination.

B. INTERNATIONAL COVENANT ON CIVIL AND POLITICAL RIGHTS, 1966

Article 17 protects individuals against arbitrary or unlawful interference with privacy. Its principles are relevant to the collection, storage and disclosure of inherited genetic information.

C. CONVENTION ON HUMAN RIGHTS AND BIOMEDICINE, 1997

The Oviedo Convention establishes protections concerning genetic testing, consent, human dignity and discrimination based on genetic heritage.

D. UNESCO INTERNATIONAL DECLARATION ON HUMAN GENETIC DATA, 2003

This Declaration addresses the collection, processing, storage and use of human genetic data. It emphasizes confidentiality, informed consent and responsible research practices.

4. CROSS-GENERATIONAL LEGAL ISSUES

A. GENETIC PRIVACY

Genetic information may reveal information about biological relatives who have not personally consented to testing. Consequently, healthcare institutions must balance individual confidentiality with legitimate medical interests concerning relatives.

B. INFORMED CONSENT

Genetic testing may disclose unexpected hereditary risks affecting future generations. Consent procedures should explain the purpose of testing, potential findings, limitations and possible implications for biological relatives.

C. GENETIC DISCRIMINATION

Employers, insurers and other institutions may misuse inherited genetic information to make discriminatory decisions. Legal safeguards should prevent unjustified disadvantages based on genetic characteristics.

D. REPRODUCTIVE AUTONOMY

Prospective parents may seek genetic counselling to understand hereditary conditions. Reproductive decisions must respect personal autonomy, privacy and applicable restrictions on reproductive genetic interventions.

E. INTERGENERATIONAL LIABILITY

Questions may arise where negligent genetic counselling, unauthorized disclosure or defective genetic testing causes foreseeable harm. Establishing liability requires consideration of duty of care, causation, foreseeability and legally recognized injury.

5. IMPORTANT CASE LAWS

The following judicial decisions establish relevant principles concerning genetic information, reproductive rights, medical confidentiality and scientific responsibility. Most are analogous authorities rather than direct decisions on dormant genes.

1. Moore v. Regents of the University of California (1990), 51 Cal. 3d 120

The California Supreme Court considered the legal rights associated with biological materials obtained from a patient and subsequently used for research. The case is relevant to consent, commercialization and ownership disputes involving genetic materials.

2. Greenberg v. Miami Children's Hospital Research Institute (2003), 264 F. Supp. 2d 1064

The court considered disputes concerning genetic research, patient contributions and intellectual property. It provides analogous guidance on informed consent and the commercialization of genetic discoveries.

3. Washington University v. Catalona (2007), 490 F.3d 667

The United States Court of Appeals considered ownership and control of biological research materials. Its principles are relevant to biobanks and the management of genetic samples collected across generations.

4. Association for Molecular Pathology v. Myriad Genetics, Inc. (2013), 569 U.S. 576

The United States Supreme Court held that naturally occurring DNA segments are not patentable merely because they have been isolated. The judgment is important for genetic research, biotechnology patents and the commercialization of hereditary information.

5. S. and Marper v. United Kingdom (2008), ECtHR, Applications Nos. 30562/04 and 30566/04

The European Court of Human Rights examined the retention of DNA profiles and cellular samples by law-enforcement authorities. It recognized the importance of genetic privacy under Article 8 of the European Convention on Human Rights.

6. Evans v. United Kingdom (2007), ECtHR, Application No. 6339/05

The case concerned reproductive autonomy and the withdrawal of consent relating to stored embryos. It provides analogous authority concerning reproductive decision-making and the legal implications of genetic and reproductive technologies.

6. REGULATORY AND COMPLIANCE REQUIREMENTS

Institutions conducting cross-generational genetic research should implement the following safeguards:

Obtain informed consent before collecting genetic samples.

Establish appropriate ethical review and research authorization procedures.

Protect identifiable genetic information through confidentiality and security measures.

Establish clear policies for incidental findings and disclosure of hereditary risks.

Provide qualified genetic counselling where clinically appropriate.

Prevent discriminatory use of genetic information.

Maintain transparent biobank retention and access policies.

Apply additional safeguards when research involves children or individuals unable to provide independent consent.

In India, relevant legal protections include the Digital Personal Data Protection Act, 2023, applicable medical confidentiality obligations, the Indian Council of Medical Research's National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017, and applicable clinical and research regulations.

7. FUTURE LEGAL CHALLENGES

Emerging technologies may increase the ability to identify inherited genetic variations and investigate epigenetic effects. This creates new regulatory questions concerning predictive genetic testing, genetic databases, reproductive interventions, artificial intelligence-based genetic analysis and the protection of future generations.

Legislatures may need to clarify the responsibilities of genetic testing companies, healthcare providers, research institutions and biobank operators. Special attention should be given to preventing unauthorized genetic profiling and ensuring that uncertain scientific predictions are not treated as established medical facts.

8. CONCLUSION

The cross-generational impact of dormant genes represents an important intersection of genetics, biotechnology, healthcare law and human rights. Although dormant genetic variations and epigenetic mechanisms can influence biological outcomes across generations, their expression and inheritance must be evaluated scientifically rather than assumed. International human rights principles and judicial decisions concerning genetic privacy, informed consent, biological materials and reproductive autonomy provide a foundation for responsible governance. Effective regulation must protect present individuals while considering the legitimate interests and rights of future generations.